Rates and characteristics of intensive care unit admissions and intubations among asthma-related hospitalizations

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 1, 2004, Pages 29-35

  Pendergraft, Trudy B ^a   Stanford, Richard H ^a   Beasley, Richard ^b   Stempel, David A ^c   Roberts, Craig ^d,e   McLaughlin, Trent ^d  

^a GLAXOSMITHKLINE   (United States)

^b MEDICAL RESEARCH INSTITUTE OF NEW ZEALAND   (New Zealand)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d Wolters Kluwer   (United States)

^e PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DATA BASE; DISEASE SEVERITY; FEMALE; HEALTH CARE COST; HOSPITAL ADMISSION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTUBATION; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; STANDARD; ADOLESCENT; ECONOMICS; ENDOTRACHEAL INTUBATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASTHMA; DATABASES; FEMALE; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; INTUBATION, INTRATRACHEAL; LENGTH OF STAY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS;

EID: 3843068857     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61444-5     Document Type: Article

References (42)

1. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for Asthma-United States, 1980-1999. MMWR CDC Surveill Summ. 2002;51:1-13.
2. Mannino DM, Homa DM, Pertowski CA, et al. Surveillance for Asthma-United States, 1960-1995. MMWR CDC Surveill Summ. 1998;47:1-27.
3. Weiss KB, Sullivan SD. The health economics of asthma and rhinitis, I: assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
4. US Department of Health and Human Services. Healthcare Cost and Utilization Project. Available at: http://www.ahrq.gov/data/ hcup/hcupnet.htm. Accessed March 28, 2002.
5. Berenson RA. Intensive Care Units (ICUs): Clinical Outcomes, Costs and Decision-Making. Washington, DC: US Congress of the United States, Office of Technology Assessment; 1984.
6. Knaus WA, Wagner DP, Zimmerman JE, Draper EA. Variations in mortality and length of stay in intensive care units. Ann Intern Med. 1993;118:753-761.
7. Jacobs P, Noseworthy TW. National estimates of intensive care utilization and costs: Canada and the United States. Crit Care Med. 1990;18:1282-1286.
8. Rosen RL, Bone RC. Economics of mechanical ventilation. Clin Chest Med. 1988;9:163-169.
9. Wagner DP. Economics of prolonged mechanical ventilation. Am Rev Respir Dis. 1989;140:514-518.
10. Rosen RL, Bone RC. Financial implications of ventilator care. Crit Care Clin. 1990;6:797-805.
11. Cohen IL, Booth FV. Cost containment and mechanical ventilation in the United States. New Horiz. 1994;2:283-290.
12. Stanford R, McLaughlin T, Okamoto L. The cost of asthma in the emergency department and hospital. Am J Respir Crit Care Med. 1999;160:211-215.
13. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-380.
14. CMS files for download for the prospective payment systems: Prospective payment system payment impact file (May 2001 update). Available at: http://cms.hhs.gov/providers/ pufdownload/default.asp. Accessed July 25, 2002.
15. Duan N. Smearing estimate: a parametric retransformation method. J Am Stat Assoc. 1983;78:605-610.
16. SAS Institute Inc. SAS Procedures Guide, Version X. Cary, NC: SAS Institute Inc; 2001.
17. Warren JL, Feuer E, Potosky AL, Riley GF, Lynch CF. Use of Medicare hospital and physician data to assess breast cancer incidence. Med Care. 1999;37:445-456.
18. Newton KM, Wagner EH, Ramsey SD, et al. The use of automated data to identify complications and comorbidities of diabetes: a validation study. J Clin Epidemiol. 1999;52:199-207.
19. Fisher ES, Whaley FS, Drushat WM, et al. The accuracy of Medicare's hospital claims data: progress has been made, but problems remain. Am J Public Health. 1992;82:243-248.
20. Eisner MD, Lieu TA, Chi F, et al. β-Agonists, inhaled steroids and the risk of intensive care unit admission for asthma. Eur Respir J. 2001;17:233-240.
21. Rosenthal GE, Sirio CA, Shepardson LB, Harper DL, Rotondi AJ, Cooper GS. Use of intensive care units for patients with low severity of illness. Arch Intern Med. 1998;158:1144-1151.
22. Rosenberg AL, Watts C. Patients readmitted to ICUs: a systematic review of risk factors and outcomes. Chest. 2000;118:492-502.
23. Rosenberg AL, Hofer TP, Hayward RA, Strachan C, Watts CM. Who bounces back? physiologic and other predictors of intensive care unit readmission. Crit Care Med. 2001;29:511-518.
24. Lin RY, Rehman A. Clinical characteristics of adult asthmatics requiring intubation. J Med. 1995;26:261-277.
25. Williams TJ, Tuxen DV, Scheinkestel CD, Czarny D, Bowes G. Risk factors for morbidity in mechanically ventilated patients with acute severe asthma. Am Rev Respir Dis. 1992;146:607-615.
26. Tan WC, Lim KP, Ng TP, Chao T, Ong YY, Chee YC. Long-term outcome and disease control in near-fatal asthma. Ann Acad Med. 1999;28:384-388.
27. Mansel K, Stogner SW, Petrini MF, Norman JR. Mechanical ventilation in patients with acute severe asthma. Am J Med. 1990;89:42-48.
28. Molfino NA, Nannini LJ, Rebuck AS, Slutsky AS. The fatality-prone asthmatic patient: follow-up study after near fatal attacks. Chest. 1992;101:621-623.
29. Richards G, Kolbe J, Fenwick J, Rea H. Demographic characteristics of patients with severe life-threatening asthma: comparison with asthma deaths. Thorax. 1993;48:1105-1109.
30. Marquette CH, Saulnier F, Leroy O, et al. Long-term prognosis of near-fatal asthma: a 6 year follow-up study of 145 asthmatic patients who underwent mechanical ventilation for a near-fatal attack of asthma. Am Rev Respir Dis. 1992;146:76-81.
31. Wasserfallen JB, Schaller MD, Feihl F, Perret CH. Sudden asphyxic asthma: a distinct entity? Am Rev Respir Dis. 1990;142:108-111.
32. Rea HH, Scragg R, Jackson R, Beaglehole R, Fenwick J, Sutherland DC. A case-control study of deaths from asthma. Thorax. 1986;41:833-839.
33. Crane J, Pearce NE, Burgess C, Woodman K, Robson B, Beasley R. Markers of risk of asthma death or readmission in the 12 months following a hospital admission for asthma. Int J Epidemiol. 1992;21:737-744.
34. Campbell DA, McLennan G, Coates JR, et al. A comparison of asthma deaths and near-fatal asthma attacks in South Australia. Eur Respir J. 1994;7:490-497.
35. Beasley R, Pearce N, Crane J. Use of near fatal asthma for investigating asthma deaths. Thorax. 1993;48:1093-1094.
36. Guidelines for the Diagnosis and Management of Asthma: Update on Selected Topics 2002. Bethesda, MD: National Heart, Lung, and Blood Institute, National Institutes of Health; June 2002. NIH publication 02-5075.
37. Suissa S, Ernst P. Inhaled corticosteroids: impact on asthma morbidity and mortality. J Allergy Clin Immunol. 2001;107:937-944.
38. Sin DD, Man SF. Low-dose inhaled corticosteroid therapy and risk of emergency department visits for asthma. Arch Intern Med. 2002;162:1591-1595.
39. Suissa S, Ernst P, Kezouh A. Regular use of inhaled corticosteroids and the long term prevention of hospitalization for asthma. Thorax. 2002;57:880-884.
40. Lanes SF, Garcia Rodriguez LA, Huerta C. Respiratory medications and risk of asthma death. Thorax. 2002;57:683-686.
41. Abramson MJ, Bailey MJ, Couper FJ, et al. Are asthma medications and management related to deaths from asthma? Am J Respir Crit Care Med. 2001;163:12-18.
42. Gibson PG, Coughlan J, Wilson AJ, et al. Self-management education and regular practitioner review for adults with asthma [Cochrane Review on CD-ROM]. Oxford, England: Cochrane Library, Update Software; 2002;issue 2.